secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001213900-25-030102
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharma enters 12-month option for castanospermine license with Florida State
--------------------------------------------------------------------------------

- Entered exclusive 12-month option to negotiate a royalty-bearing license for castanospermine purification technology.
- Company holds 8.8 kg of Australian Chestnut extract inventory for potential botanical product commercialization.
- Castanospermine is a bioactive alkaloid; company already owns IP on synthetic derivative celgosivir for viral diseases.
- Company states the option agreement is not material to its business or operations.
- Intends to explore non-prescription botanical extracts under changing U.S. regulatory framework.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025030102/0001213900-25-030102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390025030102/ea0237280-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer